(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-Hexol (133-43-7)

Identification
Properties
Melting Point:	166-168 deg C
Boiling Point:	290-295 deg C @ 3.5 mm Hg
Solubility:	1 g in about 5.5 ml water; more sol in hot water; insol in ether; sol in pyridine, aniline; sol in aq soln of alkalies; 1 g dissolves in 18 ml glycerol (density 1.24); 1 g dissolves in about 83 ml alc In water, 2.16X10+5 mg/l @ 25 deg C
Color:	Orthorhombic needles from alc WHITE, CRYSTALLINE POWDER OR FREE FLOWING GRANULES
Safety Data

Other Product

(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
hexadecanoic acid; (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol; 2-(2-hydroxyethoxy)ethanol; (Z)-octadec-9-enoic acid
6-Azabicyclo[3.1.0]hexane-2,3-diol, 4-(hydroxymethyl)-6-methyl-, (1R,2R,3R,4R,5R)- (9CI)
6-Azabicyclo[3.1.0]hexane-2,3-diol, 4-(hydroxymethyl)-, (1R,2R,3R,4R,5R)- (9CI)
(2R,2’R,3R,3’R,4R,4’R,5R,5’R)-((hexane-1,6-diylbis(azanediyl))bis(9H-purine-6,9-diyl))bis(5-(acetoxymethyl)tetrahydrofuran-2,3,4-triyl) tetraacetate
(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-(benzylamino)-2-(hydroxymethyl)oxolan-3-ol
3-Pyrrolidineaceticacid, 2-carboxy-5-methyl-4-(1-methylethenyl)-, (2R,3R,4R,5R)-rel-
[(1R)-1-[2-[(2R,3R,4R,5S,6R)-2-[[(3S,4R,5R,6S)-3,6-dihydroxy-5-[[(3R)-3-hydroxytetradecanoyl]amino]-4-[(3R)-3-hydroxytetradecanoyl]oxy-tetrahydropyran-2-yl]methoxy]-3-[[(3R)-3-dodecanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxy-tetrahydropy
(10S,13S,16S)-16-[(2-{[(2S)-2-aminopropanoyl]amino}phenyl)carbonyl]-10-(1H-indol-3-ylmethyl)-2,2-dimethyl-13-[2-(methylsulfanyl)ethyl]-4,8,11,14-tetraoxo-3-oxa-5,9,12,15-tetraazaoctadecan-18-oic acid - (2R,3S,4R,5R)-1-(methylamino)hexane-1,2,3,4,5,6-hexol
(2S,3S,4R,5R,6R)-6-({(2R,3R,4R,5R,6R)-6-({(2R,3S,4R,5R,6R)-2-carboxy-6-{[(1R,2S,3R,4R)-1,3-dihydroxy-5-oxo-4-(sulfoamino)-1-(sulfooxy)pentan-2-yl]oxy}-4-hydroxy-5-[(sulfooxy)methyl]tetrahydro-2H-pyran-3-yl}oxy)-5-(sulfoamino)-4-(sulfooxy)-2-[(sulfooxy)met
(2R)-3-{[{[(2R,3R,4S,5R,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyra
(2R)-3-{[{[(2R,3R,4S,5R,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyra
N-[(2R,3R,4R,5S,6R)-2-[(2R,3S,4R,5R)-4-[(2R,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-1-oxo-2-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-yl hydrogen phosphate (non-preferred name)
(2R)-3-{[{[(2R,3R,4R,5S,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyra
(R)-1-((2R,3R,4R,5R,6R)-3-(benzyloxy)-5-hydroxy-6-(hydroxymethyl)-4-(methoxymethoxy)tetrahydro-2H-pyran-2-yl)-7-((tert-butyldiphenylsilyl)oxy)-6-hydroxyheptan-3-one
1-Oxaspiro[2.5]octan-6-ol,5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-,(3S,4R,5R,6S)-rel-
[4,8'-Bi-2H-1-benzopyran]-3,3',5,5',7,7'-hexol,2'-(3,5-dihydroxy-4-methoxyphenyl)-3,3',4,4'-tetrahydro-2-(4-hydroxyphenyl)-,(2R,2'R,3R,3'R,4R)-
(3R,4R,7S)-4,7-bis(tert-butyldimethylsilyloxy)-7-[(2R,5R,6S)-5-ethyl-5-(4-methoxybenzyloxy)-6-methyltetrahydropyran-2-yl]-3-(4-methoxybenzyloxy)oct-1-yne